Yu, Yu
Li, Yangan
Wang, Shiqi
Liu, Feiwen
Wang, Yang
Jiang, Wenzhou
Zhu, Minjian
Li, Ran
Wang, Fengyi
Li, Lijuan
Wang, Xingyu
Zhang, Zhiqing
He, Chengqi
Wu, Dagai
Li, Wei
Luo, Lun
Fu, Chenying
Wei, Quan https://orcid.org/0000-0002-0541-905X
Funding for this research was provided by:
Sichuan Science and Technology Program (2026NSFSC1568)
Sichuan Science and Technology Program (2026NSFSC1566)
Sichuan Science and Technology Program (2023NSFSC1999)
National Key Research and Development Program of China (2023YFC3603804)
National Key Research and Development Program of China (2023YFC3603800)
Natural of Science Foundation of China (82372574)
Article History
Received: 21 June 2026
Accepted: 11 August 2026
First Online: 15 August 2026
Declarations
Ethical approval and consent to participate: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. The study protocol was approved by the Biomedical Ethics Committee of West China Hospital, Sichuan University (2023–2321). Written informed consent was obtained from all participants, and the study was registered with the Chinese Clinical Trial Registry (ChiCTR2400085313).
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.